Conflict of interest

被引:28
作者
Holmes, DR
Firth, BG
James, A
Winslow, R
Hodgson, PK
Gamble, GL
Popp, RL
Harrington, RA
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA
[2] Cordis Corp, Warren, NJ USA
[3] The Lancet, London, England
[4] Wall St Journal, New York, NY USA
[5] Duke Clin Res Inst, Durham, NC USA
[6] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
10.1016/j.ahj.2003.12.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical research enterprise is increasingly scrutinized, in part because of the issue of conflict of interest. The issue is broad and its implications. touch on a wide range of concerns, from the safety of patient care to the viability of a large industry. Numerous constituencies are affected by conflict of interest, and representatives of all of them convened in November 2002 for a one-and-a-half day discussion of the issues as well as possible solutions to both the perception and the actuality of such conflict. Participants included medical journal editors, news reporters, physician investigators, representatives of institutional conflict-of-interest oversight committees, representatives of the medical products industry, and Federal regulators. The resulting manuscript provides a review of the issues as well as desirable ways for each of the players to monitor themselves; each section thus contains provocative recommendations for eliminating conflict of interest to ensure that our vibrant health care system continues to foster exciting new advances to improve patient care.
引用
收藏
页码:228 / 237
页数:10
相关论文
共 22 条
[1]  
*AM SOC NEWSP ED, 1998, JOURN CRED PROJ
[2]  
[Anonymous], PHRMA COD INT HEALTH
[3]   Scope and impact of financial conflicts of interest in biomedical research - A systematic review [J].
Bekelman, JE ;
Li, Y ;
Gross, CP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04) :454-465
[4]  
*COUNC ETH JUD AFF, 1999, CONFL INT BIOM RES
[5]   Sponsorship, authorship, and accountability [J].
Davidoff, F ;
DeAngelis, CD ;
Drazen, JM ;
Hoey, J ;
Hojgaard, L ;
Horton, R ;
Kotzin, S ;
Nicholls, MG ;
Nylenna, M ;
Overbeke, AJPM ;
Sox, HC ;
Van Der Weyden, MB ;
Wilkes, MS .
LANCET, 2001, 358 (9285) :854-856
[6]   Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism [J].
Dong, BJ ;
Hauck, WW ;
Gambertoglio, JG ;
Gee, L ;
White, JR ;
Bubp, JL ;
Greenspan, FS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (15) :1205-1213
[7]  
FLETCHER RH, 1992, ANN INTERN MED, V116, P951, DOI 10.7326/0003-4819-116-11-951
[8]   The sacking of JAMA [J].
Horton, R .
LANCET, 1999, 353 (9149) :252-253
[9]   Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [J].
Hrachovec, JB ;
Mora, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19) :2398-2398
[10]  
*INT COMM MED J ED, 2001, UN REQ MAN SUBM BIOM